JP2024502598A - ケタミンの経口投与 - Google Patents
ケタミンの経口投与 Download PDFInfo
- Publication number
- JP2024502598A JP2024502598A JP2023541536A JP2023541536A JP2024502598A JP 2024502598 A JP2024502598 A JP 2024502598A JP 2023541536 A JP2023541536 A JP 2023541536A JP 2023541536 A JP2023541536 A JP 2023541536A JP 2024502598 A JP2024502598 A JP 2024502598A
- Authority
- JP
- Japan
- Prior art keywords
- ketamine
- aspirin
- composition
- oral
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163135126P | 2021-01-08 | 2021-01-08 | |
| US63/135,126 | 2021-01-08 | ||
| US202163176654P | 2021-04-19 | 2021-04-19 | |
| US63/176,654 | 2021-04-19 | ||
| US202163235413P | 2021-08-20 | 2021-08-20 | |
| US63/235,413 | 2021-08-20 | ||
| PCT/US2022/011630 WO2022150597A1 (en) | 2021-01-08 | 2022-01-07 | Oral administration of ketamine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024502598A true JP2024502598A (ja) | 2024-01-22 |
| JP2024502598A5 JP2024502598A5 (cg-RX-API-DMAC7.html) | 2025-01-16 |
Family
ID=82323518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023541536A Pending JP2024502598A (ja) | 2021-01-08 | 2022-01-07 | ケタミンの経口投与 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US11382873B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4274557A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024502598A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022150597A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3505157T3 (da) | 2017-12-29 | 2022-02-28 | Celon Pharma Sa | Tørpulver-ketaminsammensætning til pulmonal indgivelse ved behandlingsresistent depression |
| US20240009145A1 (en) * | 2022-07-07 | 2024-01-11 | Vitalis Analgesics LLC | Compositions of aspirin and ketamine |
| WO2025160483A1 (en) * | 2024-01-24 | 2025-07-31 | Awakn Ls Europe Holdings Limited | Oral transmucosal esketamine therapy for alcohol use disorder and substance use disorders |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040224020A1 (en) * | 2002-12-18 | 2004-11-11 | Schoenhard Grant L. | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
| JP2009543875A (ja) * | 2006-07-19 | 2009-12-10 | ワトソン ラボラトリーズ、インコーポレイテッド | 制御性放出製剤および関連する方法 |
| JP2010532358A (ja) * | 2007-07-01 | 2010-10-07 | ピーター ハバウシ,ジョセフ | 咀嚼可能外層を有する配合剤 |
| WO2018102488A1 (en) * | 2016-11-30 | 2018-06-07 | Wolfson Philip E | Ketamine for the treatment of menstrually related symptoms |
| WO2020086673A1 (en) * | 2018-10-26 | 2020-04-30 | Guangzhou Dazhou Biomedicine Ltd. | Ketamine oral transmucosal delivery system |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5840731A (en) * | 1995-08-02 | 1998-11-24 | Virginia Commonwealth University | Pain-alleviating drug composition and method for alleviating pain |
| US20030035839A1 (en) * | 2001-05-15 | 2003-02-20 | Peirce Management, Llc | Pharmaceutical composition for both intraoral and oral administration |
| CN107669649A (zh) * | 2012-10-11 | 2018-02-09 | Ix生物制药有限公司 | 固体剂型 |
| KR20220044380A (ko) * | 2013-04-12 | 2022-04-07 | 이칸 스쿨 오브 메디슨 엣 마운트 시나이 | 외상후 스트레스 장애의 치료 방법 |
| US20150072005A1 (en) * | 2013-09-10 | 2015-03-12 | Vitalis Llc | Aspirin formulation for increased efficacy |
| US11471415B2 (en) * | 2017-10-10 | 2022-10-18 | Douglas Pharmaceuticals, Ltd. | Extended release pharmaceutical formulation and methods of treatment |
| CN114805139B (zh) * | 2018-01-10 | 2023-10-20 | 凯瑞康宁生物工程(武汉)有限公司 | 氯胺酮的前药、其组合物和用途 |
| AU2019447630A1 (en) * | 2019-05-31 | 2021-12-23 | Celon Pharma S.A. | Electronically supervised administration of a pharmaceutical composition |
| US20210308075A1 (en) * | 2020-04-07 | 2021-10-07 | Joseph Habboushe | Prevention and treatment of virial infections |
-
2021
- 2021-08-25 US US17/412,110 patent/US11382873B1/en active Active
-
2022
- 2022-01-07 JP JP2023541536A patent/JP2024502598A/ja active Pending
- 2022-01-07 WO PCT/US2022/011630 patent/WO2022150597A1/en not_active Ceased
- 2022-01-07 EP EP22737179.6A patent/EP4274557A4/en active Pending
- 2022-06-10 US US17/837,501 patent/US12691082B2/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040224020A1 (en) * | 2002-12-18 | 2004-11-11 | Schoenhard Grant L. | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
| JP2009543875A (ja) * | 2006-07-19 | 2009-12-10 | ワトソン ラボラトリーズ、インコーポレイテッド | 制御性放出製剤および関連する方法 |
| JP2010532358A (ja) * | 2007-07-01 | 2010-10-07 | ピーター ハバウシ,ジョセフ | 咀嚼可能外層を有する配合剤 |
| WO2018102488A1 (en) * | 2016-11-30 | 2018-06-07 | Wolfson Philip E | Ketamine for the treatment of menstrually related symptoms |
| WO2020086673A1 (en) * | 2018-10-26 | 2020-04-30 | Guangzhou Dazhou Biomedicine Ltd. | Ketamine oral transmucosal delivery system |
Non-Patent Citations (2)
| Title |
|---|
| CLINE, A. E. AND TURRENTINE, J. E.: "Compounded Topical Analgesics for Chronic Pain", DERMATITIS, vol. 27, no. 5, JPN6026012253, 2016, pages 263 - 271, ISSN: 0005826419 * |
| RAPEPORT, D. A. ET AL.: "The Use of "Ketofol" (Ketamine-propofol Admixture) Infusion in Conjunction with Regional Anaesthes", ANAESTHESIA AND INTENSIVE CARE, vol. 37, no. 1, JPN6026012252, 2009, pages 121 - 123, ISSN: 0005826418 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022150597A1 (en) | 2022-07-14 |
| US20230077183A1 (en) | 2023-03-09 |
| US11382873B1 (en) | 2022-07-12 |
| EP4274557A1 (en) | 2023-11-15 |
| US20220218626A1 (en) | 2022-07-14 |
| EP4274557A4 (en) | 2024-12-25 |
| US12691082B2 (en) | 2026-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20070059361A1 (en) | Fast-disintegrating epinephrine tablets for buccal or sublingual administration | |
| US20230077183A1 (en) | Oral administration of ketamine | |
| US20230225994A1 (en) | Sublingual epinephrine formulations and methods of use | |
| US20180228797A1 (en) | Pharmaceutical compositions | |
| TW202317101A (zh) | 治療抑鬱狀態之方法 | |
| US20230338367A1 (en) | Treatment of prurigo nodularis | |
| US20130274342A1 (en) | Compositions and methods for treating cough | |
| JP2023545372A (ja) | デクスメデトミジン塩酸塩を用いた双極性障害及び精神病の治療 | |
| ES2671926T3 (es) | Comprimido recubierto en seco que contiene tegafur, gimeracilo y oteracilo potásico | |
| US20250099402A1 (en) | Compositions of aspirin and ketamine | |
| CN112703000B (zh) | 慢性咳嗽、呼吸急促和呼吸困难的治疗 | |
| JP2006508122A (ja) | チザニジンの頬及び舌下デリバリーのための医薬組成物及び投与形態並びにチザニジンを舌下又は頬に投与する方法 | |
| EP2248516A1 (en) | Orally disintegrating compositions of emoxypine | |
| JP7656339B2 (ja) | 疼痛を緩和するためのイブプロフェン及びトラマドールの組合せ | |
| JP2026515132A (ja) | 抑うつ状態を治療するための方法 | |
| HK40109451A (en) | Treatment of chronic cough, breathlessness and dyspnea | |
| TW201434495A (zh) | 阿戈美拉汀(agomelatine)之頰給藥之固態醫藥組合物 | |
| HK40067137A (en) | Combination of ibuprofen and tramadol for relieving pain | |
| HK40067137B (en) | Combination of ibuprofen and tramadol for relieving pain | |
| JP2013032408A (ja) | 口中溶解型又は咀嚼型鼻炎治療用固形内服医薬組成物 | |
| HK40045293B (en) | Treatment of chronic cough, breathlessness and dyspnea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250107 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250107 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260327 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20260626 |